Resource Use, Costs and Clinical Outcomes among COPD Patients Who Initiate Therapy with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要